{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T19:31:21Z","timestamp":1791228681006,"version":"4.1.0"},"reference-count":134,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2002,1,1]],"date-time":"2002-01-01T00:00:00Z","timestamp":1009843200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Human Pathology"],"published-print":{"date-parts":[[2002,1]]},"DOI":"10.1053\/hupa.2002.30221","type":"journal-article","created":{"date-parts":[[2002,7,26]],"date-time":"2002-07-26T11:23:34Z","timestamp":1027682614000},"page":"7-20","source":"Crossref","is-referenced-by-count":124,"title":["From centrocytic to mantle cell lymphoma: A clinicopathologic and molecular review of 3 decades"],"prefix":"10.1053","volume":"33","author":[{"given":"Steven H.","family":"Swerdlow","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael E.","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1053\/hupa.2002.30221_bib1","first-page":"29","article-title":"Cytological and functional criteria for the classification of malignant lymphomata","volume":"31","author":"Lennert","year":"1975","journal-title":"Br J Cancer"},{"key":"10.1053\/hupa.2002.30221_bib2","first-page":"115","article-title":"Mantle-cell lymphoma","volume":"36","author":"Campo","year":"1999","journal-title":"Semin Hematol"},{"key":"10.1053\/hupa.2002.30221_bib3","first-page":"171","article-title":"Centrocytic lymphoma: A distinct clinicopathologic, immunophenotypic, and genotypic entity","volume":"28","author":"Swerdlow","year":"1993","journal-title":"Pathol Annu"},{"key":"10.1053\/hupa.2002.30221_bib4","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0308-2261(74)80005-6","article-title":"Histopathology of malignant lymphomas","volume":"3","author":"Berard","year":"1974","journal-title":"Clin Haematol"},{"key":"10.1053\/hupa.2002.30221_bib5","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/S0046-8177(87)80262-9","article-title":"Lymphocytic lymphoma of intermediate differentiation-mantle zone lymphoma: A distinct subtype of B-cell lymphoma","volume":"18","author":"Jaffe","year":"1987","journal-title":"Hum Pathol"},{"key":"10.1053\/hupa.2002.30221_bib6","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1097\/00000478-199008000-00007","article-title":"Lymphocytic lymphoma of intermediate differentiation. Morphologic and immunophenotypic spectrum and clinical correlations","volume":"14","author":"Lardelli","year":"1990","journal-title":"Am J Surg Pathol"},{"key":"10.1053\/hupa.2002.30221_bib7","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1002\/1097-0142(19810915)48:6<1415::AID-CNCR2820480625>3.0.CO;2-N","article-title":"Malignant lymphoma, intermediate lymphocytic type: A clinicopathologic study of 42 cases","volume":"48","author":"Weisenburger","year":"1981","journal-title":"Cancer"},{"key":"10.1053\/hupa.2002.30221_bib8","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1002\/1097-0142(19820401)49:7<1429::AID-CNCR2820490720>3.0.CO;2-5","article-title":"Mantle-zone lymphoma: A follicular variant of intermediate lymphocytic lymphoma","volume":"49","author":"Weisenburger","year":"1982","journal-title":"Cancer"},{"key":"10.1053\/hupa.2002.30221_bib9","first-page":"406","article-title":"Classification of non-Hodgkin's lymphomas","volume":"2","author":"Gerard-Marchant","year":"1974","journal-title":"Lancet"},{"key":"10.1053\/hupa.2002.30221_bib10","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1038\/bjc.1980.27","article-title":"Morphological and immunological definition of a malignant lymphoma derived from germinal-centre cells with cleaved nuclei (centrocytes)","volume":"41","author":"Tolksdorf","year":"1980","journal-title":"Br J Cancer"},{"key":"10.1053\/hupa.2002.30221_bib11","series-title":"Histopathology of Non-Hodgkin's Lymphomas (Based on the Kiel Classification)","author":"Lennert","year":"1981"},{"key":"10.1053\/hupa.2002.30221_bib12","first-page":"181","article-title":"Centrocytic lymphoma: A distinct clinicopathologic and immunologic entity. A multiparameter study of 18 cases at diagnosis and relapse","volume":"113","author":"Swerdlow","year":"1983","journal-title":"Am J Pathol"},{"key":"10.1053\/hupa.2002.30221_bib13","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1002\/hon.2900030404","article-title":"Neoplastic and reactive follicles within B-cell malignant lymphomas. A morphological and immunological study of 30 cases","volume":"3","author":"Pileri","year":"1985","journal-title":"Hematol Oncol"},{"key":"10.1053\/hupa.2002.30221_bib14","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1084\/jem.155.2.623","article-title":"Infrequent normal B lymphocytes express features of B-chronic lymphocytic leukemia","volume":"155","author":"Caligaris-Cappio","year":"1982","journal-title":"J Exp Med"},{"key":"10.1053\/hupa.2002.30221_bib15","first-page":"262","article-title":"Immunohistologic characterization of two malignant lymphomas of germinal center type (centroblastic\/centrocytic and centrocytic) with monoclonal antibodies. Follicular and diffuse lymphomas of small-cleaved-cell type are related but distinct entities","volume":"117","author":"Harris","year":"1984","journal-title":"Am J Pathol"},{"key":"10.1053\/hupa.2002.30221_bib16","first-page":"329","article-title":"Centrocytic lymphoma: A morphometric study with comparison to other small cleaved follicular center cell lymphomas and genotypic correlates","volume":"142","author":"Swerdlow","year":"1993","journal-title":"Am J Pathol"},{"key":"10.1053\/hupa.2002.30221_bib17","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1097\/00000478-199207000-00001","article-title":"Mantle cell lymphoma. A proposal for unification of morphologic, immunologic, and molecular data","volume":"16","author":"Banks","year":"1992","journal-title":"Am J Surg Pathol"},{"key":"10.1053\/hupa.2002.30221_bib18","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1093\/oxfordjournals.annonc.a058904","article-title":"European Lymphoma Task Force (ELTF)","volume":"5","author":"Zucca","year":"1994","journal-title":"Ann Oncol"},{"key":"10.1053\/hupa.2002.30221_bib19","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1182\/blood.V89.6.2067","article-title":"Mantle cell lymphoma: A clinicopathologic study of 80 cases","volume":"89","author":"Argatoff","year":"1997","journal-title":"Blood"},{"key":"10.1053\/hupa.2002.30221_bib20","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1093\/oxfordjournals.annonc.a059154","article-title":"Mantle cell lymphoma: Natural history defined in a serially biopsied population over a 20-year period","volume":"6","author":"Norton","year":"1995","journal-title":"Ann Oncol"},{"key":"10.1053\/hupa.2002.30221_bib21","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1182\/blood.V85.4.1075.bloodjournal8541075","article-title":"A clinical analysis of two indolent lymphoma entities: mantle cell lymphoma and marginal zone lymphoma (including the mucosa-associated lymphoid tissue and monocytoid B-cell subcategories): A Southwest Oncology Group study","volume":"85","author":"Fisher","year":"1995","journal-title":"Blood"},{"key":"10.1053\/hupa.2002.30221_bib22","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1200\/JCO.1997.15.4.1664","article-title":"Mantle cell lymphoma: Correlation of clinical outcome and biologic features with three histologic variants","volume":"15","author":"Majlis","year":"1997","journal-title":"J Clin Oncol"},{"key":"10.1053\/hupa.2002.30221_bib23","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1016\/S0002-9440(10)65684-2","article-title":"Homing receptor alpha4beta7 integrin expression predicts digestive tract involvement in mantle cell lymphoma","volume":"153","author":"Geissmann","year":"1998","journal-title":"Am J Pathol"},{"key":"10.1053\/hupa.2002.30221_bib24","first-page":"334a","article-title":"Evidence for need of upper and lower endoscopies with biopsy in staging of asymptomatic patients with aggressive mantle cell lymphoma (MCL)","volume":"96","author":"Romaguera","year":"2000","journal-title":"Blood"},{"key":"10.1053\/hupa.2002.30221_bib25","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1097\/00000478-199605000-00009","article-title":"The morphologic spectrum of non-Hodgkin's lymphomas with BCL1\/cyclin D1 gene rearrangements","volume":"20","author":"Swerdlow","year":"1996","journal-title":"Am J Surg Pathol"},{"key":"10.1053\/hupa.2002.30221_bib26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00022744-200003000-00001","article-title":"Classification of small B-cell lymphoid neoplasms using a paraffin section immunohistochemical panel","volume":"8","author":"Chen","year":"2000","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"10.1053\/hupa.2002.30221_bib27","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1126\/science.6610211","article-title":"Molecular cloning of the chromosomal breakpoint of B-cell lymphomas and leukemias with the t(11;14) chromosome translocation","volume":"224","author":"Tsujimoto","year":"1984","journal-title":"Science"},{"key":"10.1053\/hupa.2002.30221_bib28","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1038\/350512a0","article-title":"A novel cyclin encoded by a bcl1-linked candidate oncogene","volume":"350","author":"Motokura","year":"1991","journal-title":"Nature"},{"key":"10.1053\/hupa.2002.30221_bib29","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1016\/0092-8674(91)90042-W","article-title":"Isolation of three novel human cyclins by rescue of G1 cyclin (Cln) function in yeast","volume":"66","author":"Lew","year":"1991","journal-title":"Cell"},{"key":"10.1053\/hupa.2002.30221_bib30","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/0092-8674(91)90100-D","article-title":"Human D-type cyclin","volume":"65","author":"Xiong","year":"1991","journal-title":"Cell"},{"key":"10.1053\/hupa.2002.30221_bib31","doi-asserted-by":"crossref","first-page":"4846","DOI":"10.1128\/MCB.11.10.4846","article-title":"Characterization of a candidate bcl-1 gene","volume":"11","author":"Withers","year":"1991","journal-title":"Mol Cell Biol"},{"key":"10.1053\/hupa.2002.30221_bib32","first-page":"355","article-title":"Identification and cloning of two overexpressed genes, U21B31\/PRAD1 and EMS1, within the amplified chromosome 11q13 region in human carcinomas","volume":"7","author":"Schuuring","year":"1992","journal-title":"Oncogene"},{"key":"10.1053\/hupa.2002.30221_bib33","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1002\/gcc.2870020310","article-title":"Break in the BCL1 locus is closely associated with intermediate lymphocytic lymphoma subtype","volume":"2","author":"Rimokh","year":"1990","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1053\/hupa.2002.30221_bib34","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1182\/blood.V76.7.1387.1387","article-title":"Genotypic characterization of centrocytic lymphoma: Frequent rearrangement of the chromosome 11 bcl-1 locus","volume":"76","author":"Williams","year":"1990","journal-title":"Blood"},{"key":"10.1053\/hupa.2002.30221_bib35","doi-asserted-by":"crossref","first-page":"2086","DOI":"10.1182\/blood.V76.10.2086.2086","article-title":"Association of bcl-1 rearrangements with lymphocytic lymphoma of intermediate differentiation","volume":"76","author":"Medeiros","year":"1990","journal-title":"Blood"},{"key":"10.1053\/hupa.2002.30221_bib36","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1182\/blood.V78.2.493.493","article-title":"Rearrangement of the chromosome 11 bcl-1 locus in centrocytic lymphoma: Analysis with multiple breakpoint probes","volume":"78","author":"Williams","year":"1991","journal-title":"Blood"},{"key":"10.1053\/hupa.2002.30221_bib37","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/978-3-642-77633-5_41","article-title":"Centrocytic lymphoma: A B-cell non-Hodgkin's lymphoma characterized by chromosome 11 bcl-1 and PRAD 1 rearrangements","volume":"182","author":"Williams","year":"1992","journal-title":"Curr Top Microbiol Immunol"},{"key":"10.1053\/hupa.2002.30221_bib38","first-page":"5541s","article-title":"Characterization of chromosome 11 translocation breakpoints at the bcl-1 and PRAD1 loci in centrocytic lymphoma","volume":"52","author":"Williams","year":"1992","journal-title":"Cancer Res"},{"key":"10.1053\/hupa.2002.30221_bib39","first-page":"241","article-title":"Chromosome 11 translocation breakpoints at the PRAD1\/cyclin D1 gene locus in centrocytic lymphoma","volume":"7","author":"Williams","year":"1993","journal-title":"Leukemia"},{"key":"10.1053\/hupa.2002.30221_bib40","first-page":"1437","article-title":"Chromosome t(11;14)(q13;q32) breakpoints in centrocytic lymphoma are highly localized at the bcl-1 major translocation cluster","volume":"7","author":"Williams","year":"1993","journal-title":"Leukemia"},{"key":"10.1053\/hupa.2002.30221_bib41","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1093\/ajcp\/104.6.689","article-title":"Detection of bcl-1 gene rearrangement and B-cell clonality in mantle cell lymphoma using formalin-fixed, paraffin-embedded tissues","volume":"104","author":"Lim","year":"1995","journal-title":"Am J Clin Pathol"},{"key":"10.1053\/hupa.2002.30221_bib42","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1097\/00019606-199503000-00003","article-title":"Polymerase chain reaction detection of the t(11;14) translocation involving the bcl-1 major translocation cluster in mantle cell lymphoma","volume":"4","author":"Luthra","year":"1995","journal-title":"Diagn Mol Pathol"},{"key":"10.1053\/hupa.2002.30221_bib43","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1182\/blood.V83.6.1626.1626","article-title":"Antigen expression and polymerase chain reaction amplification of mantle cell lymphomas","volume":"83","author":"Molot","year":"1994","journal-title":"Blood"},{"key":"10.1053\/hupa.2002.30221_bib44","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1093\/clinchem\/47.2.195","article-title":"Quantitative real-time reverse transcription-PCR assay for cyclin D1 expression: Utility in the diagnosis of mantle cell lymphoma","volume":"47","author":"Bijwaard","year":"2001","journal-title":"Clin Chem"},{"key":"10.1053\/hupa.2002.30221_bib45","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1016\/0046-8177(95)90090-X","article-title":"Expression of cyclin D1 protein in centrocytic\/mantle cell lymphomas with and without rearrangement of the BCL1\/cyclin D1 gene","volume":"26","author":"Swerdlow","year":"1995","journal-title":"Hum Pathol"},{"key":"10.1053\/hupa.2002.30221_bib46","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1093\/ajcp\/103.6.756","article-title":"Cyclin D1 expression in non-Hodgkin's lymphomas. Detection by immunohistochemistry","volume":"103","author":"Zukerberg","year":"1995","journal-title":"Am J Clin Pathol"},{"key":"10.1053\/hupa.2002.30221_bib47","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1093\/oxfordjournals.annonc.a059161","article-title":"In situ hybridization detection of cyclin D1 mRNA in centrocytic\/mantle cell lymphoma","volume":"6","author":"Williams","year":"1995","journal-title":"Ann Oncol"},{"key":"10.1053\/hupa.2002.30221_bib48","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1007\/978-3-642-79275-5_39","article-title":"Mantle cell\/centrocytic lymphoma: molecular and phenotypic analysis including analysis of the bcl-1 major translocation cluster by PCR","volume":"194","author":"Williams","year":"1995","journal-title":"Curr Top Microbiol Immunol"},{"key":"10.1053\/hupa.2002.30221_bib49","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1093\/annonc\/5.suppl_1.S71","article-title":"Cyclin D1 overexpression in non-Hodgkin's lymphoma with chromosome 11 bcl-1 rearrangement","volume":"5","author":"Williams","year":"1994","journal-title":"Ann Oncol"},{"key":"10.1053\/hupa.2002.30221_bib50","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.5858\/2000-124-1457-MIAOTC","article-title":"Multiparameter immunohistochemical analysis of the cell cycle proteins cyclin D1, Ki-67, p21WAF1, p27KIP1, and p53 in mantle cell lymphoma","volume":"124","author":"Izban","year":"2000","journal-title":"Arch Pathol Lab Med"},{"key":"10.1053\/hupa.2002.30221_bib51","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1097\/00022744-200003000-00009","article-title":"Optimized cyclin D1 immunoperoxidase staining in mantle cell lymphoma","volume":"8","author":"Korin","year":"2000","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"10.1053\/hupa.2002.30221_bib52","first-page":"2253","article-title":"Significance of cyclin D1 overexpression for the diagnosis of mantle cell lymphoma: A clinicopathologic comparison of cyclin D1-positive MCL and cyclin D1-negative MCL-like B-cell lymphoma","volume":"95","author":"Yatabe","year":"2000","journal-title":"Blood"},{"key":"10.1053\/hupa.2002.30221_bib53","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1182\/blood.V88.4.1177.bloodjournal8841177","article-title":"Direct visualization of dispersed 11q13 chromosomal translocations in mantle cell lymphoma by multicolor DNA fiber fluorescence in situ hybridization","volume":"88","author":"Vaandrager","year":"1996","journal-title":"Blood"},{"key":"10.1053\/hupa.2002.30221_bib54","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1093\/annonc\/8.suppl_2.S109","article-title":"Bcl-1\/cyclin D1 in malignant lymphoma","volume":"8","author":"de Boer","year":"1997","journal-title":"Ann Oncol"},{"key":"10.1053\/hupa.2002.30221_bib55","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1182\/blood.V87.4.1512.bloodjournal8741512","article-title":"Detection of 11q13 rearrangements in hematologic neoplasias by double-color fluorescence in situ hybridization","volume":"87","author":"Coignet","year":"1996","journal-title":"Blood"},{"key":"10.1053\/hupa.2002.30221_bib56","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1016\/S0002-9440(10)65399-0","article-title":"Detection of translocation t(11;14)(q13;q32) in mantle cell lymphoma by fluorescence in situ hybridization","volume":"154","author":"Li","year":"1999","journal-title":"Am J Pathol"},{"key":"10.1053\/hupa.2002.30221_bib57","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1046\/j.1365-2141.1998.00700.x","article-title":"Multiple myeloma and the translocation t(11;14)(q13;q32): A report on 13 cases","volume":"101","author":"Fonseca","year":"1998","journal-title":"Br J Haematol"},{"key":"10.1053\/hupa.2002.30221_bib58","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0165-4608(97)00469-X","article-title":"Cytogenetics in multiple myeloma: a multicenter study of 24 patients with t(11;14)(q13;q32) or its variant","volume":"104","author":"Lai","year":"1998","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1053\/hupa.2002.30221_bib59","first-page":"1743","article-title":"Multicolor spectral karyotyping identifies new recurring breakpoints and translocations in multiple myeloma","volume":"92","author":"Rao","year":"1998","journal-title":"Blood"},{"key":"10.1053\/hupa.2002.30221_bib60","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1111\/j.1365-2141.1999.01314.x","article-title":"Molecular analysis of bcl-1\/IgH junctional sequences in mantle cell lymphoma: Potential mechanism of the t(11;14) chromosomal translocation","volume":"105","author":"Stamatopoulos","year":"1999","journal-title":"Br J Haematol"},{"key":"10.1053\/hupa.2002.30221_bib61","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1056\/NEJM199911113412007","article-title":"Cellular origin of human B-cell lymphomas","volume":"341","author":"Kuppers","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1053\/hupa.2002.30221_bib62","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1182\/blood.V88.2.674.bloodjournal882674","article-title":"Dysregulation of cyclin D1 by translocation into an IgH gamma switch region in two multiple myeloma cell lines","volume":"88","author":"Chesi","year":"1996","journal-title":"Blood"},{"key":"10.1053\/hupa.2002.30221_bib63","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1182\/blood.V91.1.3","article-title":"Multiple myeloma: Increasing evidence for a multistep transformation process","volume":"91","author":"Hallek","year":"1998","journal-title":"Blood"},{"key":"10.1053\/hupa.2002.30221_bib64","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1093\/oxfordjournals.annonc.a010568","article-title":"Involvement of the CCND1 gene in hairy cell leukemia","volume":"7","author":"de Boer","year":"1996","journal-title":"Ann Oncol"},{"key":"10.1053\/hupa.2002.30221_bib65","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1111\/j.1365-2141.1995.tb05429.x","article-title":"Increased expression of the PRAD-1\/CCND1 gene in hairy cell leukaemia","volume":"91","author":"Bosch","year":"1995","journal-title":"Br J Haematol"},{"key":"10.1053\/hupa.2002.30221_bib66","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1038\/modpathol.3880144","article-title":"Blastic mantle cell leukemia: An unusual presentation of blastic mantle cell lymphoma","volume":"13","author":"Viswanatha","year":"2000","journal-title":"Mod Pathol"},{"key":"10.1053\/hupa.2002.30221_bib67","first-page":"601","article-title":"Absence of cyclin D1 protein expression in splenic marginal zone lymphoma","volume":"11","author":"Savilo","year":"1998","journal-title":"Mod Pathol"},{"key":"10.1053\/hupa.2002.30221_bib68","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1016\/S0002-9440(10)65710-0","article-title":"Differential expression of cyclin D1 in mantle cell lymphoma and other non-Hodgkin's lymphomas","volume":"153","author":"Aguilera","year":"1998","journal-title":"Am J Pathol"},{"key":"10.1053\/hupa.2002.30221_bib69","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1126\/science.274.5293.1672","article-title":"Cancer cell cycles","volume":"274","author":"Sherr","year":"1996","journal-title":"Science"},{"key":"10.1053\/hupa.2002.30221_bib70","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/0092-8674(94)90543-6","article-title":"Cyclins and cancer. II: Cyclin D and CDK inhibitors come of age","volume":"79","author":"Hunter","year":"1994","journal-title":"Cell"},{"key":"10.1053\/hupa.2002.30221_bib71","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1182\/blood.V86.3.841.841","article-title":"Role of the cyclin-dependent kinase inhibitors in the development of cancer","volume":"86","author":"Hirama","year":"1995","journal-title":"Blood"},{"key":"10.1053\/hupa.2002.30221_bib72","doi-asserted-by":"crossref","first-page":"2939","DOI":"10.1101\/gad.8.24.2939","article-title":"Growth suppression by p18, a p16INK4\/MTS1- and p14INK4B\/MTS2-related CDK6 inhibitor, correlates with wild-type pRb function","volume":"8","author":"Guan","year":"1994","journal-title":"Genes Dev"},{"key":"10.1053\/hupa.2002.30221_bib73","doi-asserted-by":"crossref","first-page":"2672","DOI":"10.1128\/MCB.15.5.2672","article-title":"Novel INK4 proteins, p19 and p18, are specific inhibitors of the cyclin D-dependent kinases CDK4 and CDK6","volume":"15","author":"Hirai","year":"1995","journal-title":"Mol Cell Biol"},{"key":"10.1053\/hupa.2002.30221_bib74","doi-asserted-by":"crossref","first-page":"2682","DOI":"10.1128\/MCB.15.5.2682","article-title":"Identification of human and mouse p19, a novel CDK4 and CDK6 inhibitor with homology to p16ink4","volume":"15","author":"Chan","year":"1995","journal-title":"Mol Cell Biol"},{"key":"10.1053\/hupa.2002.30221_bib75","first-page":"1049","article-title":"Cyclins D1 and D2 are differentially expressed in human B-lymphoid cell lines","volume":"8","author":"Palmero","year":"1993","journal-title":"Oncogene"},{"key":"10.1053\/hupa.2002.30221_bib76","doi-asserted-by":"crossref","first-page":"3997","DOI":"10.1182\/blood.V94.12.3997","article-title":"Regulated genomic instability and neoplasia in the lymphoid lineage","volume":"94","author":"Vanasse","year":"1999","journal-title":"Blood"},{"key":"10.1053\/hupa.2002.30221_bib77","first-page":"3447","article-title":"Overexpression of cyclin D1 in rat fibroblasts causes abnormalities in growth control, cell cycle progression and gene expression","volume":"8","author":"Jiang","year":"1993","journal-title":"Oncogene"},{"key":"10.1053\/hupa.2002.30221_bib78","doi-asserted-by":"crossref","first-page":"8022","DOI":"10.1073\/pnas.91.17.8022","article-title":"Cyclin D1 induction in breast cancer cells shortens G1 and is sufficient for cells arrested in G1 to complete the cell cycle","volume":"91","author":"Musgrove","year":"1994","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1053\/hupa.2002.30221_bib79","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1101\/gad.7.8.1559","article-title":"Overexpression of mouse D-type cyclins accelerates G1 phase in rodent fibroblasts","volume":"7","author":"Quelle","year":"1993","journal-title":"Genes Dev"},{"key":"10.1053\/hupa.2002.30221_bib80","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/0092-8674(94)90540-1","article-title":"G1 phase progression: Cycling on cue","volume":"79","author":"Sherr","year":"1994","journal-title":"Cell"},{"key":"10.1053\/hupa.2002.30221_bib81","first-page":"323","article-title":"Oncogenic activity of cyclin D1 revealed through cooperation with Ha-ras: Link between cell cycle control and malignant transformation","volume":"9","author":"Lovec","year":"1994","journal-title":"Oncogene"},{"key":"10.1053\/hupa.2002.30221_bib82","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1073\/pnas.91.2.709","article-title":"Function of a human cyclin gene as an oncogene","volume":"91","author":"Hinds","year":"1994","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1053\/hupa.2002.30221_bib83","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1038\/369669a0","article-title":"Mammary hyperplasia and carcinoma in MMTV-cyclin D1 transgenic mice","volume":"369","author":"Wang","year":"1994","journal-title":"Nature"},{"key":"10.1053\/hupa.2002.30221_bib84","doi-asserted-by":"crossref","first-page":"3487","DOI":"10.1002\/j.1460-2075.1994.tb06655.x","article-title":"Cyclin D1\/bcl-1 cooperates with myc genes in the generation of B-cell lymphoma in transgenic mice","volume":"13","author":"Lovec","year":"1994","journal-title":"EMBO J"},{"key":"10.1053\/hupa.2002.30221_bib85","doi-asserted-by":"crossref","first-page":"2124","DOI":"10.1002\/j.1460-2075.1994.tb06488.x","article-title":"Cyclin D1 transgene impedes lymphocyte maturation and collaborates in lymphomagenesis with the myc gene","volume":"13","author":"Bodrug","year":"1994","journal-title":"EMBO J"},{"key":"10.1053\/hupa.2002.30221_bib86","doi-asserted-by":"crossref","first-page":"3262","DOI":"10.1182\/blood.V94.9.3262","article-title":"Molecular characterization of 11q deletions points to a pathogenic role of the ATM gene in mantle cell lymphoma","volume":"94","author":"Stilgenbauer","year":"1999","journal-title":"Blood"},{"key":"10.1053\/hupa.2002.30221_bib87","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1182\/blood.V94.2.748","article-title":"Somatic ATM mutations indicate a pathogenic role of ATM in B-cell chronic lymphocytic leukemia","volume":"94","author":"Schaffner","year":"1999","journal-title":"Blood"},{"key":"10.1053\/hupa.2002.30221_bib88","doi-asserted-by":"crossref","first-page":"2773","DOI":"10.1073\/pnas.050400997","article-title":"Mantle cell lymphoma is characterized by inactivation of the ATM gene","volume":"97","author":"Schaffner","year":"2000","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1053\/hupa.2002.30221_bib89","doi-asserted-by":"crossref","first-page":"2412","DOI":"10.1182\/blood.V84.8.2412.2412","article-title":"p53 in hematologic malignancies","volume":"84","author":"Imamura","year":"1994","journal-title":"Blood"},{"key":"10.1053\/hupa.2002.30221_bib90","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.1182\/blood.V82.7.1994.1994","article-title":"p53 mutation is associated with progression in follicular lymphomas","volume":"82","author":"Sander","year":"1993","journal-title":"Blood"},{"key":"10.1053\/hupa.2002.30221_bib91","doi-asserted-by":"crossref","first-page":"2289","DOI":"10.1182\/blood.V82.8.2289.2289","article-title":"p53 mutations are associated with histologic transformation of follicular lymphoma","volume":"82","author":"Lo Coco","year":"1993","journal-title":"Blood"},{"key":"10.1053\/hupa.2002.30221_bib92","doi-asserted-by":"crossref","first-page":"3781","DOI":"10.1182\/blood.V84.11.3781.bloodjournal84113781","article-title":"Absence of WAF1 mutations in a variety of human malignancies","volume":"84","author":"Shiohara","year":"1994","journal-title":"Blood"},{"key":"10.1053\/hupa.2002.30221_bib93","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1182\/blood.V86.4.1269.bloodjournal8641269","article-title":"Homozygous deletions of p16\/MTS1 gene are frequent but mutations are infrequent in childhood T-cell acute lymphoblastic leukemia","volume":"86","author":"Ohnishi","year":"1995","journal-title":"Blood"},{"key":"10.1053\/hupa.2002.30221_bib94","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1182\/blood.V86.1.311.bloodjournal861311","article-title":"p16INK4A and p15INK4B gene deletions in primary leukemias","volume":"86","author":"Haidar","year":"1995","journal-title":"Blood"},{"key":"10.1053\/hupa.2002.30221_bib95","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1182\/blood.V85.4.893.bloodjournal854893","article-title":"Deletions and rearrangement of CDKN2 in lymphoid malignancy","volume":"85","author":"Stranks","year":"1995","journal-title":"Blood"},{"key":"10.1053\/hupa.2002.30221_bib96","doi-asserted-by":"crossref","first-page":"2900","DOI":"10.1182\/blood.V86.8.2900.2900","article-title":"Deletion of cyclin-dependent kinase 4 inhibitor genes P15 and P16 in non-Hodgkin's lymphoma","volume":"86","author":"Koduru","year":"1995","journal-title":"Blood"},{"key":"10.1053\/hupa.2002.30221_bib97","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1182\/blood.V86.4.1534.bloodjournal8641534","article-title":"Deletions of the cyclin-dependent kinase inhibitor genes p16INK4A and p15INK4B in non-Hodgkin's lymphomas","volume":"86","author":"Gombart","year":"1995","journal-title":"Blood"},{"key":"10.1053\/hupa.2002.30221_bib98","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1182\/blood.V85.3.854a.bloodjournal853854a","article-title":"Homozygous MTS1 (p16INK4A) deletion in primary tumor cells of 163 leukemic patients","volume":"85","author":"Cayuela","year":"1995","journal-title":"Blood"},{"key":"10.1053\/hupa.2002.30221_bib99","doi-asserted-by":"crossref","first-page":"2724","DOI":"10.1182\/blood.V86.7.2724.2724","article-title":"Mutational analysis of the CDKN2 (MTS1\/p16ink4A) gene in primary B-cell lymphomas","volume":"86","author":"Uchida","year":"1995","journal-title":"Blood"},{"key":"10.1053\/hupa.2002.30221_bib100","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1182\/blood.V86.4.1548.bloodjournal8641548","article-title":"Loss of the cyclin-dependent kinase 4-inhibitor (p16; MTS1) gene is frequent in and highly specific to lymphoid tumors in primary human hematopoietic malignancies","volume":"86","author":"Ogawa","year":"1995","journal-title":"Blood"},{"key":"10.1053\/hupa.2002.30221_bib101","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1182\/blood.V97.2.572","article-title":"Hemizygous p16(INK4A) deletion in pediatric acute lymphoblastic leukemia predicts independent risk of relapse","volume":"97","author":"Carter","year":"2001","journal-title":"Blood"},{"key":"10.1053\/hupa.2002.30221_bib102","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1126\/science.8153634","article-title":"A cell cycle regulator potentially involved in genesis of many tumor types","volume":"264","author":"Kamb","year":"1994","journal-title":"Science"},{"key":"10.1053\/hupa.2002.30221_bib103","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1182\/blood.V86.5.1931.bloodjournal8651931","article-title":"Refined mapping of genomic rearrangements involving the short arm of chromosome 9 in acute lymphoblastic leukemias and other hematologic malignancies","volume":"86","author":"Dreyling","year":"1995","journal-title":"Blood"},{"key":"10.1053\/hupa.2002.30221_bib104","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1111\/j.1365-2141.1995.tb08417.x","article-title":"Over-expression of cyclin D1 in chronic B-cell malignancies with abnormality of chromosome 11q13","volume":"89","author":"Delmer","year":"1995","journal-title":"Br J Haematol"},{"key":"10.1053\/hupa.2002.30221_bib105","first-page":"451","article-title":"Mutational analysis of the p16 family cyclin-dependent kinase inhibitors p15INK4b and p18INK4c in tumor-derived cell lines and primary tumors","volume":"12","author":"Zariwala","year":"1996","journal-title":"Oncogene"},{"key":"10.1053\/hupa.2002.30221_bib106","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1111\/j.1365-2141.1991.tb08582.x","article-title":"Non-Hodgkin's lymphomas with t(11;14)(q13;q32): A subset of mantle zone\/intermediate lymphocytic lymphoma?","volume":"77","author":"Leroux","year":"1991","journal-title":"Br J Haematol"},{"key":"10.1053\/hupa.2002.30221_bib107","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1182\/blood.V84.1.270.270","article-title":"Frequent p53 gene involvement in splenic B-cell leukemia\/lymphomas of possible marginal zone origin","volume":"84","author":"Baldini","year":"1994","journal-title":"Blood"},{"key":"10.1053\/hupa.2002.30221_bib108","doi-asserted-by":"crossref","first-page":"4302","DOI":"10.1182\/blood.V87.10.4302.bloodjournal87104302","article-title":"p53 mutations in mantle cell lymphoma are associated with variant cytology and predict a poor prognosis","volume":"87","author":"Greiner","year":"1996","journal-title":"Blood"},{"key":"10.1053\/hupa.2002.30221_bib109","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1182\/blood.V89.1.272","article-title":"Deletions and loss of expression of p16INK4a and p21Waf1 genes are associated with aggressive variants of mantle cell lymphomas","volume":"89","author":"Pinyol","year":"1997","journal-title":"Blood"},{"key":"10.1053\/hupa.2002.30221_bib110","doi-asserted-by":"crossref","first-page":"3351","DOI":"10.1182\/blood.V87.8.3351.bloodjournal8783351","article-title":"p53 gene mutations and protein overexpression are associated with aggressive variants of mantle cell lymphomas","volume":"87","author":"Hernandez","year":"1996","journal-title":"Blood"},{"key":"10.1053\/hupa.2002.30221_bib111","doi-asserted-by":"crossref","first-page":"2892","DOI":"10.1182\/blood.V86.8.2892.2892","article-title":"p53 overexpression as a marker of poor prognosis in mantle cell lymphomas with t(11;14)(q13;q32)","volume":"86","author":"Louie","year":"1995","journal-title":"Blood"},{"key":"10.1053\/hupa.2002.30221_bib112","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1038\/sj.leu.2401090","article-title":"Concurrent disruption of cell cycle associated genes in mantle cell lymphoma: A genotypic and phenotypic study of cyclin D1, p16, p15, p53 and pRb","volume":"12","author":"Gronbaek","year":"1998","journal-title":"Leukemia"},{"key":"10.1053\/hupa.2002.30221_bib113","doi-asserted-by":"crossref","first-page":"55","DOI":"10.3109\/10428199809059246","article-title":"The cytomorphological spectrum of mantle cell lymphoma is reflected by distinct biological features","volume":"32","author":"Ott","year":"1998","journal-title":"Leuk Lymphoma"},{"key":"10.1053\/hupa.2002.30221_bib114","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1182\/blood.V95.2.619","article-title":"Increased proteasome degradation of cyclin-dependent kinase inhibitor p27 is associated with a decreased overall survival in mantle cell lymphoma","volume":"95","author":"Chiarle","year":"2000","journal-title":"Blood"},{"key":"10.1053\/hupa.2002.30221_bib115","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S0002-9440(10)65558-7","article-title":"Mantle cell lymphomas lack expression of p27Kip1, a cyclin-dependent kinase inhibitor","volume":"153","author":"Quintanilla-Martinez","year":"1998","journal-title":"Am J Pathol"},{"key":"10.1053\/hupa.2002.30221_bib116","first-page":"747a","article-title":"MTS1\/MTS2 (p15\/p16) deletions and p53 mutations in mantle cell (centrocytic) lymphoma","volume":"86","author":"Williams","year":"1995","journal-title":"Blood"},{"key":"10.1053\/hupa.2002.30221_bib117","doi-asserted-by":"crossref","first-page":"2977","DOI":"10.1182\/blood.V91.8.2977.2977_2977_2984","article-title":"p16(INK4a) gene inactivation by deletions, mutations, and hypermethylation is associated with transformed and aggressive variants of non-Hodgkin's lymphomas","volume":"91","author":"Pinyol","year":"1998","journal-title":"Blood"},{"key":"10.1053\/hupa.2002.30221_bib118","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1093\/annonc\/8.suppl_2.S71","article-title":"Analysis of the cyclin-dependent kinase inhibitors p18 and p19 in mantle-cell lymphoma and chronic lymphocytic leukemia","volume":"8","author":"Williams","year":"1997","journal-title":"Ann Oncol"},{"key":"10.1053\/hupa.2002.30221_bib119","first-page":"4608","article-title":"Alterations of the cyclin D1\/p16-pRB pathway in mantle cell lymphoma","volume":"57","author":"Dreyling","year":"1997","journal-title":"Cancer Res"},{"key":"10.1053\/hupa.2002.30221_bib120","doi-asserted-by":"crossref","first-page":"3158","DOI":"10.1182\/blood.V84.9.3158.3158","article-title":"The MDM2 oncogene overexpression in chronic lymphocytic leukemia and low-grade lymphoma of B-cell origin","volume":"84","author":"Watanabe","year":"1994","journal-title":"Blood"},{"key":"10.1053\/hupa.2002.30221_bib121","first-page":"4365","article-title":"Increased number of chromosomal imbalances and high-level DNA amplifications in mantle cell lymphoma are associated with blastoid variants","volume":"93","author":"Bea","year":"1999","journal-title":"Blood"},{"key":"10.1053\/hupa.2002.30221_bib122","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1002\/(SICI)1098-2264(199804)21:4<298::AID-GCC3>3.0.CO;2-U","article-title":"Gain of 3q and deletion of 11q22 are frequent aberrations in mantle cell lymphoma","volume":"21","author":"Monni","year":"1998","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1053\/hupa.2002.30221_bib123","first-page":"594","article-title":"Secondary chromosome changes in mantle cell lymphoma","volume":"84","author":"Wlodarska","year":"1999","journal-title":"Haematologica"},{"key":"10.1053\/hupa.2002.30221_bib124","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/S0165-4608(98)00228-3","article-title":"Translocation (11;14)(q13;q32) and preferential involvement of chromosomes 1, 2, 9, 13, and 17 in mantle cell lymphoma","volume":"111","author":"Espinet","year":"1999","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1053\/hupa.2002.30221_bib125","first-page":"171","article-title":"Genetics of small lymphocyte disorders","volume":"36","author":"Panayiotidis","year":"1999","journal-title":"Semin Hematol"},{"key":"10.1053\/hupa.2002.30221_bib126","doi-asserted-by":"crossref","first-page":"2607","DOI":"10.1200\/JCO.2000.18.13.2607","article-title":"Acquired chromosome 11q deletion involving the ataxia teleangiectasia locus in B-cell non-Hodgkin's lymphoma: Correlation with clinicobiologic features","volume":"18","author":"Cuneo","year":"2000","journal-title":"J Clin Oncol"},{"key":"10.1053\/hupa.2002.30221_bib127","doi-asserted-by":"crossref","first-page":"3909","DOI":"10.1182\/blood.V89.11.3909","volume":"89","year":"1997","journal-title":"Blood"},{"key":"10.1053\/hupa.2002.30221_bib128","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/s11864-000-0041-x","article-title":"Mantle cell lymphoma","volume":"1","author":"Densmore","year":"2000","journal-title":"Curr Treatment Options Oncol"},{"key":"10.1053\/hupa.2002.30221_bib129","doi-asserted-by":"crossref","first-page":"3803","DOI":"10.1200\/JCO.1998.16.12.3803","article-title":"Hyper-CVAD and high-dose methotrexate\/cytarabine followed by stem-cell transplantation: An active regimen for aggressive mantle-cell lymphoma","volume":"16","author":"Khouri","year":"1998","journal-title":"J Clin Oncol"},{"key":"10.1053\/hupa.2002.30221_bib130","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1023\/A:1008380527502","article-title":"Allogeneic hematopoietic transplantation for mantle-cell lymphoma: Molecular remissions and evidence of graft-versus-malignancy","volume":"10","author":"Khouri","year":"1999","journal-title":"Ann Oncol"},{"key":"10.1053\/hupa.2002.30221_bib131","first-page":"631a","article-title":"Rituxan\/CHOP induction therapy in newly diagnosed patients with mantle cell lymphoma","volume":"94","author":"Howard","year":"1999","journal-title":"Blood"},{"key":"10.1053\/hupa.2002.30221_bib132","doi-asserted-by":"crossref","first-page":"2817","DOI":"10.1200\/JCO.1998.16.8.2817","article-title":"Transplant-lite: Induction of graft-versus-malignancy using fludarabine-based nonablative chemotherapy and allogeneic blood progenitor-cell transplantation as treatment for lymphoid malignancies","volume":"16","author":"Khouri","year":"1998","journal-title":"J Clin Oncol"},{"key":"10.1053\/hupa.2002.30221_bib133","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1038\/sj.bmt.1701400","article-title":"High-dose therapy with stem cell transplantation for mantle cell lymphoma: Results and prognostic factors, a single center experience","volume":"22","author":"Milpied","year":"1998","journal-title":"Bone Marrow Transplant"},{"key":"10.1053\/hupa.2002.30221_bib134","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.1200\/JCO.2000.18.9.1812","article-title":"Phase I clinical and pharmacokinetic study of Bcl-2 antisense oligonucleotide therapy in patients with non-Hodgkin's lymphoma","volume":"18","author":"Waters","year":"2000","journal-title":"J Clin Oncol"}],"container-title":["Human Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S004681770262132X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S004681770262132X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,5,16]],"date-time":"2021-05-16T06:20:48Z","timestamp":1621146048000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S004681770262132X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,1]]},"references-count":134,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2002,1]]}},"alternative-id":["S004681770262132X"],"URL":"https:\/\/doi.org\/10.1053\/hupa.2002.30221","relation":{},"ISSN":["0046-8177"],"issn-type":[{"value":"0046-8177","type":"print"}],"subject":[],"published":{"date-parts":[[2002,1]]}}}